Haemonetics Corp
HAE- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000313143
In the last 90 days, Haemonetics Corp insiders filed 0 open-market purchases and 1 sale; 357 institutions reported holding it in 13F filings for Q3 2026, worth $5.11B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:30 PM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 28, 2026 | Mar 29, 2025 | Mar 30, 2024 | Apr 1, 2023 | Apr 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 7, 2026 | May 8, 2025 | May 9, 2024 | May 11, 2023 | May 10, 2022 |
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993.2M |
| Cost of revenue | $546.4M | $611.9M | $617.5M | $553.6M | $487.7M |
| Gross profit | $787.6M | $749.0M | $691.5M | $615.1M | $505.5M |
| Operating expenses | $630.9M | $527.1M | $526.7M | $459.1M | $424.8M |
| Research and development | $59.8M | $62.7M | $54.4M | $50.1M | $46.8M |
| Selling, general and administrative | $442.4M | $436.8M | $431.8M | $376.7M | $339.6M |
| Operating income | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M |
| Interest expense | $19.3M | $35.9M | $19.5M | $13.0M | $5.80M |
| Income tax | $30.7M | $44.4M | $34.3M | $26.0M | $20.3M |
| Net income | $97.3M | $167.7M | $117.6M | $115.4M | $43.4M |
| EPS, basic | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 |
| EPS, diluted | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
| Weighted shares, basic | 47.2M | 50.3M | 50.7M | 50.8M | 51.0M |
| Weighted shares, diluted | 47.4M | 50.7M | 51.4M | 51.4M | 51.4M |
| Margins and growth | |||||
| Gross margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Operating margin | 11.7% | 16.3% | 12.6% | 13.4% | 8.1% |
| Net margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% |
| Revenue growth, year over year | −2.0% | +4.0% | +12.0% | +17.7% | +14.1% |
| Net income growth, year over year | −42.0% | +42.6% | +1.9% | +166.1% | −45.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 28, 2026 | Mar 29, 2025 | Mar 30, 2024 | Apr 1, 2023 | Apr 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 7, 2026 | May 8, 2025 | May 9, 2024 | May 11, 2023 | May 10, 2022 |
| Cash and equivalents | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M |
| Accounts receivable | $216.9M | $202.7M | $206.6M | $179.1M | $159.4M |
| Inventory | $306.4M | $365.1M | $317.2M | $259.4M | $293.0M |
| Total current assets | $834.9M | $935.0M | $768.9M | $769.7M | $756.0M |
| Property, plant and equipment | $305.8M | $284.1M | $311.4M | $310.9M | $258.5M |
| Goodwill | $656.4M | $604.3M | $565.1M | $466.2M | $467.3M |
| Intangible assets | $447.7M | $455.7M | $406.1M | $275.8M | $310.3M |
| Total assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B |
| Accounts payable | $51.1M | $67.0M | $73.4M | $63.9M | $58.4M |
| Short-term debt | $5.01M | $303.6M | $10.2M | $11.8M | $214.1M |
| Total current liabilities | $282.6M | $578.1M | $300.4M | $251.8M | $442.3M |
| Long-term debt | $1.22B | $921.2M | $797.6M | $754.1M | $559.4M |
| Shareholders' equity | $796.3M | $820.8M | $960.0M | $818.0M | $749.4M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 28, 2026 | Mar 29, 2025 | Mar 30, 2024 | Apr 1, 2023 | Apr 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | May 7, 2026 | May 8, 2025 | May 9, 2024 | May 11, 2023 | May 10, 2022 |
| Operating cash flow | $293.2M | $181.7M | $181.8M | $273.1M | $172.3M |
| Capital expenditures | $32.8M | $39.3M | $66.3M | $110.2M | $96.5M |
| Free cash flow | $260.4M | $142.4M | $115.5M | $162.9M | $75.8M |
| Depreciation and amortization | $111.7M | $115.6M | $97.2M | $93.3M | $97.7M |
| Stock-based compensation | $33.8M | $29.6M | $28.3M | $25.6M | $24.4M |
| Share buybacks | $175.0M | $225.0M | $0 | $75.0M | $0 |
| Investing cash flow | -$179.5M | -$161.9M | -$322.4M | -$143.8M | -$86.3M |
| Financing cash flow | -$178.5M | $108.8M | $38.2M | -$100.4M | -$15.7M |
| Net change in cash | -$61.3M | $128.0M | -$105.7M | $25.0M | $67.2M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.5% | 2.2% | 2.2% | 2.2% | 2.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 45.5M | −2.7% | SEC |
| Jul 31, 2026 | 45.5M | −5.6% | SEC |
| May 15, 2026 | 45.4M | −5.4% | SEC |
| Jan 30, 2026 | 46.5M | −7.5% | SEC |
| Oct 31, 2025 | 46.8M | −6.8% | SEC |
| Aug 1, 2025 | 48.2M | −5.9% | SEC |
| May 16, 2025 | 48.0M | −5.5% | SEC |
| Feb 3, 2025 | 50.2M | −1.1% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.